Showing 1 - 5 results of 5 for search 'Ou SHI' Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Author
  • Ou SHI
Showing 1 - 5 results of 5 for search 'Ou SHI', query time: 0.04s Refine Results
  1. 1
    Innovating by Behaving: How to Adopt the Startup Culture in Large Companies

    Innovating by Behaving: How to Adopt the Startup Culture in Large Companies by Ou, Shi Chao

    Published 2022
    Get full text
    Thesis
  2. 2
    Comprehensive Survey of AACR GENIE Database of Tumor Mutation Burden (TMB) Among All Three Classes (I, II, III) of BRAF Mutated (BRAF+) NSCLC

    Comprehensive Survey of AACR GENIE Database of Tumor Mutation Burden (TMB) Among All Three Classes (I, II, III) of BRAF Mutated (BRAF+) NSCLC by Arter ZL, Shieh K, Nagasaka M, Ou SHI

    Published 2025-02-01
    Get full text
    Article
  3. 3
    DCT and Wiener filter based on approach for speech enhancement using a single microphone

    DCT and Wiener filter based on approach for speech enhancement using a single microphone by OU Shi-feng, ZHAO Xiao-hui, GU Hai-jun

    Published 2006-01-01
    Get full text
    Article
  4. 4
    DCT and Wiener filter based on approach for speech enhancement using a single microphone

    DCT and Wiener filter based on approach for speech enhancement using a single microphone by OU Shi-feng, ZHAO Xiao-hui, GU Hai-jun

    Published 2006-01-01
    Get full text
    Article
  5. 5
    Time To Response In Patients With Advanced Anaplastic Lymphoma Kinase (ALK)-Positive Non-Small-Cell Lung Cancer (NSCLC) Receiving Alectinib In The Phase II NP28673 And NP28761 Studies

    Time To Response In Patients With Advanced Anaplastic Lymphoma Kinase (ALK)-Positive Non-Small-Cell Lung Cancer (NSCLC) Receiving Alectinib In The Phase II NP28673 And NP28761 Stud... by Gadgeel S, Shaw AT, Barlesi F, Crino L, Yang JCH, Dingemans AM, Kim DW, de Marinis F, Schulz M, Liu S, Gupta R, Smoljanovic V, Ou SHI

    Published 2019-11-01
    Get full text
    Article

Search Tools:

  • RSS Feed
  • Email Search

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs